EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantifying Time to Diagnosis of CKD in the United States

Adrian R Levy iD, Satabdi Chatterjee, Sydnie Stackland, Bonnie M K Donato iD, Ling Zhang iD, Csaba P Kovesdy

Kidney360 · 2026

DOI: 10.34067/kid.0000001056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, 2026. Verfasst von Adrian R Levy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Electronic Health Records, Delayed Diagnosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Many people with CKD are unaware of the condition. We estimated the time to CKD documentation after two eGFR measurements taken at least 90 days apart. Among many persons with early stage CKD, there are considerable delays in documenting the diagnosis in electronic health record-linked claims data.

Background

An estimated 14% of US adults have CKD with over 90% unaware of their condition. Health care professionals diagnose CKD after two abnormal laboratory test results taken at least 3 months apart. Although there is evidence that delays from CKD onset to documentation are common, these delays remain unquantified. The objective of this study was to quantify the time from laboratory-based evidence of CKD to the documentation of CKD using International Classification of Diseases codes.

Methods

A retrospective longitudinal cohort study was conducted using 2009–2020 Optum Market Clarity data. Adults aged 18 years and older were followed from the date of the second of two eGFRs

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicElectronic Health RecordsDelayed DiagnosisHumansFemaleRetrospective StudiesMaleUnited StatesMiddle AgedAgedLongitudinal StudiesAdultTime FactorsGlomerular Filtration RateInternational Classification of DiseasesDocumentation

Stichwörter der Autor:innen

CKDclinical epidemiologyhealth policy

Autor:innen und Institutionen

  • Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut.
  • Panalgo, Boston, Massachusetts.
  • University of Tennessee Health Science Center, Nashville, Tennessee.

ORCID-Profile: Adrian R Levy, Bonnie M K Donato, Ling Zhang

Förderung

  • Boehringer Ingelheim

Zitieren

APA

Levy, A. R., Chatterjee, S., Stackland, S., Donato, B. M. K., Zhang, L., & Kovesdy, C. P. (2026). Quantifying Time to Diagnosis of CKD in the United States. Kidney360. https://doi.org/10.34067/kid.0000001056

Vancouver

Levy AR, Chatterjee S, Stackland S, Donato BMK, Zhang L, Kovesdy CP. Quantifying Time to Diagnosis of CKD in the United States. Kidney360. 2026. doi:10.34067/kid.0000001056

BibTeX
@article{Levy2026,
  author = {Levy, Adrian R and Chatterjee, Satabdi and Stackland, Sydnie and Donato, Bonnie M K and Zhang, Ling and Kovesdy, Csaba P},
  title = {Quantifying Time to Diagnosis of CKD in the United States},
  journal = {Kidney360},
  year = {2026},
  doi = {10.34067/kid.0000001056}
}
Kostenlos starten →